Clovis Oncology Inc (NASDAQ:CLVS)
During the Trading Day
| 33.50 |  +0.21 / +0.63% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 33.50 |  0.00 / 0.00% |
Volume: 1.1K |
Latest CLVS News | Press Releases
No recent news for Clovis Oncology Inc.
Today’s Trading
| Previous close | 33.29 |
| Today’s open | 32.74 |
| Day’s range | 32.32 - 33.83 |
| Volume | 194,019 |
| Average volume (3 months) | 152,209 |
| Market cap | $874.4M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/23/2013
Growth & Valuation
| Earnings growth (last year) | -39.63% |
| Earnings growth (this year) | +6.48% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| USNAUSANA Health Science... | +0.37 | +0.54% |
| NBIXNeurocrine Bioscienc... | +0.70 | +5.83% |
| AUXLAuxilium Pharmaceuti... | +0.02 | +0.13% |
| ACHNAchillion Pharmaceut... | -0.10 | -1.29% |
Data as of 4:00pm ET, 05/23/2013
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.69 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$74.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Patrick J. Mahaffy |
Chief Financial Officer, Secretary & Executive VP Erle T. Mast |
Corporate headquarters Boulder, Colorado |
Forecasts
